Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beibei Guo

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Pharmaceutical Statistics|December 26, 2024
A Phase I Dose-Finding Design Incorporating Intra-Patient Dose EscalationBeibei Guo, Suyu Liu
Biometrical Journal. Biometrische Zeitschrift|August 13, 2019
An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpointsBeibei Guo, Suyu Liu
Statistical Methods in Medical Research|September 20, 2018
A Bayesian adaptive phase II clinical trial design accounting for spatial variationBeibei Guo, Yong Zang
Statistical Methods in Medical Research|April 3, 2015
A comparative review of methods for comparing means using partially paired dataBeibei Guo, Ying Yuan
Statistics in Medicine|August 28, 2020
BILITE: A Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacyBeibei Guo, Yong Zang
Plos One|July 26, 2018
Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statisticsRenee Dale, BeiBei Guo
Statistics in Medicine|November 22, 2014
Bayesian dose-finding designs for combination of molecularly targeted agents assuming partial stochastic orderingBeibei Guo, Yisheng Li
Statistics in Medicine|January 29, 2015
A Bayesian dose-finding design for phase I/II clinical trials with nonignorable dropoutsBeibei Guo, Ying Yuan
Statistical Methods in Medical Research|February 22, 2022
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapyBeibei Guo, Yong Zang
Journal of the American Statistical Association|September 1, 2020
Bayesian Phase I/II Biomarker-based Dose Finding for Precision Medicine with Molecularly Targeted AgentsBeibei Guo, Ying Yuan
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Pharmaceutical Statistics|December 26, 2024
A Phase I Dose-Finding Design Incorporating Intra-Patient Dose EscalationBeibei Guo, Suyu Liu
Biometrical Journal. Biometrische Zeitschrift|August 13, 2019
An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpointsBeibei Guo, Suyu Liu
Statistical Methods in Medical Research|September 20, 2018
A Bayesian adaptive phase II clinical trial design accounting for spatial variationBeibei Guo, Yong Zang
Statistical Methods in Medical Research|April 3, 2015
A comparative review of methods for comparing means using partially paired dataBeibei Guo, Ying Yuan
Statistics in Medicine|August 28, 2020
BILITE: A Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacyBeibei Guo, Yong Zang
Plos One|July 26, 2018
Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statisticsRenee Dale, BeiBei Guo
Statistics in Medicine|November 22, 2014
Bayesian dose-finding designs for combination of molecularly targeted agents assuming partial stochastic orderingBeibei Guo, Yisheng Li
Statistics in Medicine|January 29, 2015
A Bayesian dose-finding design for phase I/II clinical trials with nonignorable dropoutsBeibei Guo, Ying Yuan
Statistical Methods in Medical Research|February 22, 2022
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapyBeibei Guo, Yong Zang
Journal of the American Statistical Association|September 1, 2020
Bayesian Phase I/II Biomarker-based Dose Finding for Precision Medicine with Molecularly Targeted AgentsBeibei Guo, Ying Yuan
Pageof 15